Universal Vision Biotechnology Co Ltd (3218)

Currency in TWD
204.50
0.00(0.00%)
Delayed Data·
3218 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
3218 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
203.00208.00
52 wk Range
158.50264.00
Key Statistics
Bid/Ask
336.50 / 337.00
Prev. Close
198
Open
204
Day's Range
203-208
52 wk Range
158.5-264
Volume
-
Average Volume (3m)
163.19K
1-Year Change
-10.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3218 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
212.50
Upside
+3.91%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 12 consecutive years
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Universal Vision Biotechnology Co Ltd Company Profile

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

Employees
401
Market
Taiwan

Compare 3218 to Peers and Sector

Metrics to compare
3218
Peers
Sector
Relationship
P/E Ratio
15.6x21.1x−0.5x
PEG Ratio
4.220.060.00
Price/Book
5.2x1.2x2.6x
Price / LTM Sales
4.1x3.4x3.3x
Upside (Analyst Target)
2.9%0.0%40.6%
Fair Value Upside
Unlock33.4%5.3%Unlock

Analyst Ratings

0 Buy
2 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 212.50
(+3.91% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 13.26%
Dividend Yield
3.88%
Industry Median 3.64%
Annualised payout
7.50
Paid annually
5-Years Growth
+33.08%
Growth Streak

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
3.31 / 3.30
Revenue / Forecast
1.08B / 1.08B
EPS Revisions
Last 90 days

3218 Income Statement

FAQ

What Stock Exchange Does Universal Vision BioTech Trade On?

Universal Vision BioTech is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Universal Vision BioTech?

The stock symbol for Universal Vision BioTech is "3218."

What Is the Universal Vision BioTech Market Cap?

As of today, Universal Vision BioTech market cap is 17.33B.

What Is Universal Vision BioTech's Earnings Per Share (TTM)?

The Universal Vision BioTech EPS (TTM) is 13.26.

When Is the Next Universal Vision BioTech Earnings Date?

Universal Vision BioTech will release its next earnings report on 17 Nov 2025.

From a Technical Analysis Perspective, Is 3218 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Universal Vision BioTech Stock Split?

Universal Vision BioTech has split 9 times.

How Many Employees Does Universal Vision BioTech Have?

Universal Vision BioTech has 401 employees.

What is the current trading status of Universal Vision BioTech (3218)?

As of 15 Aug 2025, Universal Vision BioTech (3218) is trading at a price of 204.50, with a previous close of 198.00. The stock has fluctuated within a day range of 203.00 to 208.00, while its 52-week range spans from 158.50 to 264.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.